What My Patients Are Asking: Explain the New Breast Cancer Staging Guidelines

What My Patients Are Asking: Explain the New Breast Cancer Staging Guidelines

Brian Wojciechowski, MD, explains the TNM parts of the staging system and how the characteristics added to the staging system in 2018 affect a cancer's stage.
Sep 17, 2019
/_next/static/media/art.743baba8.png
00:00
Download
00:00

In 2018, the American Joint Committee on Cancer, commonly called the AJCC, updated breast cancer staging guidelines to add other information to how a cancer’s stage is determined. This has made determining the stage of a breast cancer more complex, but also more accurate.

Listen to the podcast to hear Dr. Wojciechowski explain:

  • what the T, N, and M parts of the staging system mean

  • how the new characteristics added to the staging system in 2018 — cancer grade, estrogen receptor status, progesterone receptor status, HER2 receptor status, and Oncotype DX Recurrence Score — affect a breast cancer’s stage

  • how a cancer that might have been stage IIIA in the past might now be stage IB

About the guest
 
Brian Wojciechowski headshot
Brian Wojciechowski, MD

Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.

— Last updated on July 31, 2022, 10:20 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate